Mettler-Toledo International, Inc. (NYSE:MTD) Shares Bought by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. boosted its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 11.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 38,237 shares of the medical instruments supplier's stock after purchasing an additional 3,867 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.18% of Mettler-Toledo International worth $45,154,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC increased its stake in shares of Mettler-Toledo International by 39.1% during the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock valued at $103,000 after acquiring an additional 25 shares during the last quarter. QRG Capital Management Inc. grew its holdings in Mettler-Toledo International by 29.4% in the first quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier's stock valued at $577,000 after purchasing an additional 111 shares during the period. Royal Bank of Canada increased its position in Mettler-Toledo International by 7.3% during the fourth quarter. Royal Bank of Canada now owns 45,756 shares of the medical instruments supplier's stock worth $55,990,000 after purchasing an additional 3,105 shares during the last quarter. Renaissance Technologies LLC raised its stake in Mettler-Toledo International by 31.3% during the fourth quarter. Renaissance Technologies LLC now owns 12,600 shares of the medical instruments supplier's stock worth $15,418,000 after purchasing an additional 3,000 shares during the period. Finally, Truist Financial Corp boosted its holdings in shares of Mettler-Toledo International by 1.3% in the 4th quarter. Truist Financial Corp now owns 1,053 shares of the medical instruments supplier's stock valued at $1,289,000 after purchasing an additional 14 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

MTD has been the subject of a number of research analyst reports. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price objective for the company in a report on Monday, April 7th. Robert W. Baird lowered their price target on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating for the company in a research report on Tuesday, April 22nd. Barclays began coverage on Mettler-Toledo International in a report on Tuesday. They issued an "overweight" rating and a $1,325.00 price objective on the stock. Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and reduced their price objective for the company from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Finally, Wall Street Zen downgraded shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research report on Monday, May 5th. Eight equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $1,300.36.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock traded down $8.91 during midday trading on Friday, hitting $1,184.40. 163,651 shares of the company were exchanged, compared to its average volume of 152,544. The company has a market cap of $24.61 billion, a PE ratio of 29.54, a price-to-earnings-growth ratio of 3.53 and a beta of 1.38. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93. The company's fifty day moving average price is $1,130.39 and its 200-day moving average price is $1,198.86.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. The company had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The business's quarterly revenue was down 4.6% on a year-over-year basis. During the same quarter last year, the firm posted $8.89 earnings per share. On average, analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the sale, the director now directly owns 120 shares in the company, valued at $139,191.60. The trade was a 89.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.94% of the stock is currently owned by company insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.